Results 161 to 170 of about 432,885 (215)

Pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural mesothelioma-<i>ex vivo</i> evaluation of optimal treatment conditions and comparison with hyperthermic intrathoracic chemotherapy (HITOC). [PDF]

J Thorac Dis
Flöthmann K, Zinne N, Braubach P, Meininger A, Becker I, Ernst N, Ruhparwar A, Merhej H, Zardo P.   +8 more
europepmc   +1 more source

Malignant Pleural Mesothelioma: A 2025 Update. [PDF]

J Clin Med
Cardillo G, Waller D, Tenconi S, Di Noia V, Ricciardi S.   +4 more
europepmc   +1 more source

The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves. [PDF]

Curr Oncol Rep
Kucukoner M, Demir T, Alsubaie AM, Alabalik U, Ibrahim AK, Pierobon M, Liotta L.   +6 more
europepmc   +1 more source

Proteomics of malignant pleural mesothelioma under hypoxic and normoxic conditions in a large animal (porcine) tumor model. [PDF]

BMC Cancer
Min W, He D, Liu X, Zhu X, Cui B, Cao W, Zuo Z, Wang J, Ye Z, Tang X, Yong S, Xiong S, Jin D, Zhao S, Gou Y.   +14 more
europepmc   +1 more source

Hematogenous dissemination of malignant pleural mesothelioma: An autopsy case of gallbladder metastasis causing obstructive jaundice. [PDF]

Respir Med Case Rep
Okamoto S, Shinomiya M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Malignant Pleural Mesothelioma

Current Oncology Reports, 2011
Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease.
Siva, Raja, Sudish C, Murthy, David P, Mason   +2 more
openaire   +2 more sources

[Malignant pleural mesothelioma].

Minerva chirurgica, 2001
Malignant pleural mesothelioma is a severe disease closely associated with asbestos exposure, at work or environmental. Its incidence has risen for some decades and it's expected to peak between 2010 and 2020. Up today, no treatment has been demonstrated as effective in influencing disease-related survival and the median prognosis ranges between 9 and ...
Rena Ottavio, Oliaro Alberto.
openaire   +5 more sources